Circulating tumor DNA analysis for assessment of recurrence risk, benefit of adjuvant therapy, and early relapse detection after treatment in colorectal cancer patients.

作者
Tenna Vesterman Henriksen,Noelia Tarazona,Thomas Reinert,Juan Antonio Carbonell‐Asins,Derrick Renner,Shruti Sharma,Desamparados Roda,Marisol Huerta,Susana Roselló,Lene Hjerrild Iversen,Kåre Andersson Gotschalck,Anders Husted Madsen,Per Vadgaard Andersen,Ole Thorlacius‐Ussing,Uffe S. Løve,Himanshu Sethi,Alexey A. Aleshin,Andrès M.R. Cervantes,Claus L. Andersen
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:39 (3_suppl): 11-11 被引量:30
标识
DOI:10.1200/jco.2021.39.3_suppl.11
摘要

11 Background: Timely detection of recurrence, as well as identification of patients at high risk of recurrence after surgery and after completion of adjuvant therapy, are major challenges in the treatment of colorectal cancer (CRC). Postsurgical circulating tumor DNA (ctDNA) analysis is a promising tool for the identification of patients with minimal residual disease (MRD) and a high risk of recurrence. The objective of this prospective, multicenter study was to determine whether serial postsurgical ctDNA analysis could identify the patients at high risk of recurrence, provide an assessment of adjuvant therapy efficacy and detect relapse earlier than standard-of-care radiological imaging. Methods: The cohort comprises 265 stage I-III CRC patients, the to-date largest cohort assessed for ctDNA. All patients had the tumor resected and a subset of 62.6% (166 /265) was additionally treated with ACT. Plasma samples (n = 1503) were collected at various time points for a median follow-up of 28.4 months (range: 1.2-51.0 months). Individual tumors and matched germline DNA were whole-exome sequenced and somatic single nucleotide variants (SNVs) were identified. Personalized multiplex PCR assays were designed to track tumor-specific SNVs (Signatera, bespoke mPCR NGS assay) in each patient’s plasma sample. Results: Postoperative ctDNA status prior to ACT was assessed in 218 patients, of which 9.17% (20/218) were identified to be MRD-positive and 75% (15/20) eventually relapsed. The remaining 25% (5/20) of MRD-positive patients that did not relapse, received ACT. In contrast, only 13.6% (27/198) of MRD-negative cases relapsed (HR: 11: 95% CI: 5.7-20; p < 0.001). Longitudinal ctDNA-positive status, post-definitive therapy (n = 202) was associated with a HR of 36 (95% CI: 16-81; p < 0.001). For a subset of 155 patients postoperative CEA and ctDNA measurements were compared, wherein, ctDNA-positive status was found to be significantly associated with RFS (HR, 7.1; 95% CI, 3.4-15; P < 0.001) compared to CEA (HR, 1.2; 95% CI, 0.46-3.1; P = 0.73). Serial ctDNA analysis detected MRD up to a median of 8 months (0.56 - 21.6 months) ahead of radiologic relapse. Conclusion: Postoperative ctDNA positive status was associated with markedly reduced RFS compared to CEA. The study also shows that effective therapy can be curative in a portion of MRD-positive patients. In a longitudinal setting, ctDNA analysis predicted the risk of recurrence and is a more reliable biomarker for treatment response monitoring.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
思源的应助被嘻嘻哈哈顺利采纳,获得30
1秒前
zgm完成签到,获得积分10
1秒前
1秒前
王人捷发布了新的文献求助30
3秒前
搜集达人的应助被追寻夏槐采纳,获得20
3秒前
BIGDUCK完成签到,获得积分10
4秒前
FashionBoy的应助被vc采纳,获得10
4秒前
5秒前
6秒前
GG酱发布了新的文献求助30
6秒前
酷波er的应助被眼睛大初之采纳,获得10
7秒前
8秒前
田様的应助被鹦鹉采纳,获得10
8秒前
黄橙橙完成签到 ,获得积分10
9秒前
9秒前
syvshc的应助被含蓄的冰绿采纳,获得10
10秒前
lucky完成签到 ,获得积分10
11秒前
11秒前
12秒前
Ferry完成签到,获得积分10
13秒前
13秒前
JH_Yang发布了新的文献求助10
14秒前
Nole的应助被hannah采纳,获得10
15秒前
zZZZ发布了新的文献求助10
16秒前
16秒前
Ryan发布了新的文献求助10
16秒前
17秒前
西红柿发布了新的文献求助10
17秒前
123发布了新的文献求助10
17秒前
欢呼半山完成签到 ,获得积分10
17秒前
18秒前
18秒前
桐桐的应助被清水烫春菜采纳,获得10
20秒前
Ava的应助被酷酷的悒采纳,获得10
20秒前
20秒前
科研通AI6.2的应助被12采纳,获得10
20秒前
21秒前
22秒前
23秒前
开心小懒虫完成签到,获得积分10
23秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Agyptische Geschichte der 21.30. Dynastie 510
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192776
求助须知:如何正确求助?哪些是违规求助? 9579206
关于积分的说明 21864151
捐赠科研通 7792348
什么是DOI,文献DOI怎么找? 3437041
关于科研通互助平台的介绍 2560633
邀请新用户注册赠送积分活动 2483916